Hikal Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Partnering with Pharmaceutical, Life Sciences, Biotech & Specialty Chemicals Companies to deliver APIs, Intermediate & R&D Services.
One of their notable products is EMPAGLIFLOZIN, with a corresponding US DMF Number 32570.
Remarkably, this DMF maintains an Active status since its submission on September 12, 2018, highlighting commitment to regulatory compliance.